<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Neuralstem, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Neuralstem, Inc.

    Neuralstem is a biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. Our lead asset, NSI-189, is a new chemical entity in Phase 2 clinical development for major depressive disorder (MDD). Our transplantational stem cell asset, NSI-566, is a spinal cord-derived neural stem cell line being tested in stroke, chronic spinal cord injury (cSCI) and Amyotrophic Lateral Sclerosis (ALS). These product candidates are based on the company’s proprietary neural stem cell technology. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth C. Carter, Ph.D.
    • FOUNDED
      1996
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    SCWorx Corp.

    SCWorx Corp.

    SCWorx offers an advanced software solution for the management of health care prov...

    SCWorx offers an advanced software solution for...

    Filing Type:    PU
    Precipio, Inc.

    Precipio, Inc.

    Precipio has built a platform designed to eradicate the problem of misdiagnosis by...

    Precipio has built a platform designed to eradi...

    Filing Type:    PU
    DENTSPLY SIRONA Inc.

    DENTSPLY SIRONA Inc.

    Dentsply Sirona is the world’s largest manufacturer of professional dental produ...

    Dentsply Sirona is the world’s largest manufa...

    Filing Type:    PU
    Sanofi

    Sanofi

    Sanofi is dedicated to supporting people through their health challenges. We are a...

    Sanofi is dedicated to supporting people throug...

    Filing Type:    PU
    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focu...

    Paratek Pharmaceuticals, Inc. is a commercial-s...

    Filing Type:    PU
    aTyr Pharma, Inc.

    aTyr Pharma, Inc.

    aTyr’s mission is to translate newly discovered biological pathways to develop i...

    aTyr’s mission is to translate newly discover...

    Filing Type:    PU
    Omeros Corporation

    Omeros Corporation

    Omeros is a commercial-stage biopharmaceutical company committed to discovering, d...

    Omeros is a commercial-stage biopharmaceutical ...

    Filing Type:    PU
    Aptinyx Inc.

    Aptinyx Inc.

    Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and develop...

    Aptinyx Inc. is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing th...

    Cyclerion Therapeutics is a clinical-stage biop...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    Tokio Marine Holdings, Inc.

    Tokio Marine Holdings, Inc.

    Tokio Marine Group is a global insurance group that provides safety and security t...

    Tokio Marine Group is a global insurance group ...

    Filing Type:    PU
    Diamond Hill Investment Group, Inc.

    Diamond Hill Investment Group, Inc.

    We are an independent investment management firm with significant employee ownersh...

    We are an independent investment management fir...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.